Hevroni D, Livneh Z
Department of Biochemistry, Weizmann Institute of Science, Rehovot, Israel.
Proc Natl Acad Sci U S A. 1988 Jul;85(14):5046-50. doi: 10.1073/pnas.85.14.5046.
Mutations produced in Escherichia coli by apurinic sites are believed to arise via SOS-assisted translesion replication. Analysis of replication products synthesized on depurinated single-stranded DNA by DNA polymerase III holoenzyme revealed that apurinic sites frequently blocked in vitro replication. Bypass frequency of an apurinic site was estimated to be 10-15%. Direct evidence for replicative bypass was obtained in a complete single-stranded----replicative form replication system containing DNA polymerase III holoenzyme, single-stranded DNA binding protein, DNA polymerase I, and DNa ligase, by demonstrating the sensitivity of fully replicated products to the apurinic endonuclease activity of E. coli exonuclease III. Termination at apurinic sites, like termination at pyrimidine photodimers, involved dissociation of the polymerase from the blocked termini, followed by initiations at available primer templates. When no regular primer templates were available, the polymerase underwent repeated cycles of dissociation and rebinding at the blocked termini and, while bound, carried out multiple polymerization-excision reactions opposite the apurinic sites, leading to turnover of dNTPs into dNMPs. From the in vitro turnover rates, we could predict with striking accuracy the specificity of apurinic site mutagenesis, as determined in vivo in depurinated single-stranded DNA from an M13-lac hybrid phage. This finding is consistent with the view that DNA polymerase III holoenzyme carries out the mutagenic "misinsertion" step during apurinic site mutagenesis in vivo and that the specificity of the process is determined primarily by the polymerase. SOS-induced proteins such as UmuD/C might act as processivity-like factors to stabilize the polymerase-DNA complex, thus increasing the efficiency of the next stage of past-lesion polymerization required to complete the bypass reaction.
人们认为,大肠杆菌中由脱嘌呤位点产生的突变是通过SOS辅助的跨损伤复制产生的。对DNA聚合酶III全酶在脱嘌呤单链DNA上合成的复制产物进行分析后发现,脱嘌呤位点经常会阻断体外复制。脱嘌呤位点的绕过频率估计为10 - 15%。在一个完整的单链——复制形式复制系统中,该系统包含DNA聚合酶III全酶、单链DNA结合蛋白、DNA聚合酶I和DNA连接酶,通过证明完全复制的产物对大肠杆菌核酸外切酶III的脱嘌呤内切酶活性敏感,获得了复制绕过的直接证据。在脱嘌呤位点的终止,就像在嘧啶光二聚体处的终止一样,涉及聚合酶从受阻末端解离,随后在可用的引物模板处起始。当没有常规的引物模板可用时,聚合酶在受阻末端经历解离和重新结合的重复循环,并且在结合时,在脱嘌呤位点对面进行多次聚合 - 切除反应,导致dNTPs转化为dNMPs。根据体外周转率,我们能够极其准确地预测脱嘌呤位点诱变的特异性,这是在体内对来自M13 - lac杂交噬菌体的脱嘌呤单链DNA进行测定的。这一发现与以下观点一致,即DNA聚合酶III全酶在体内脱嘌呤位点诱变过程中执行诱变的“错误插入”步骤,并且该过程的特异性主要由聚合酶决定。SOS诱导的蛋白质如UmuD/C可能作为类似持续性的因子来稳定聚合酶 - DNA复合物,从而提高完成绕过反应所需的损伤后聚合下一阶段的效率。